194 related articles for article (PubMed ID: 26179544)
21. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
[TBL] [Abstract][Full Text] [Related]
22. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
Kotanko P; Kramar R; Devrnja D; Paschke E; Voigtländer T; Auinger M; Pagliardini S; Spada M; Demmelbauer K; Lorenz M; Hauser AC; Kofler HJ; Lhotta K; Neyer U; Pronai W; Wallner M; Wieser C; Wiesholzer M; Zodl H; Födinger M; Sunder-Plassmann G
J Am Soc Nephrol; 2004 May; 15(5):1323-9. PubMed ID: 15100373
[TBL] [Abstract][Full Text] [Related]
23. Significance of screening for Fabry disease among male dialysis patients.
Ichinose M; Nakayama M; Ohashi T; Utsunomiya Y; Kobayashi M; Eto Y
Clin Exp Nephrol; 2005 Sep; 9(3):228-32. PubMed ID: 16189631
[TBL] [Abstract][Full Text] [Related]
24. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
25. GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing.
Peng H; Xu X; Zhang L; Zhang X; Peng H; Zheng Y; Luo S; Guo H; Xia K; Li J; Yao H; Hu Z
Gene; 2016 Jan; 575(2 Pt 1):363-7. PubMed ID: 26456105
[TBL] [Abstract][Full Text] [Related]
26. Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area.
Zizzo C; Testa A; Colomba P; Postorino M; Natale G; Pini A; Francofonte D; Cammarata G; Scalia S; Sciarrino S; Zoccali C; Duro G
Kidney Blood Press Res; 2018; 43(4):1344-1351. PubMed ID: 30099469
[TBL] [Abstract][Full Text] [Related]
27. Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).
Suzuki K; Miura N; Kitagawa W; Suzuki S; Komatsuda A; Nishikawa K; Watanabe D; Imai H
Clin Exp Nephrol; 2011 Dec; 15(6):916-20. PubMed ID: 21755431
[TBL] [Abstract][Full Text] [Related]
28. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
[TBL] [Abstract][Full Text] [Related]
29. De novo mutation in a male patient with Fabry disease: a case report.
Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
[TBL] [Abstract][Full Text] [Related]
30. Effects of a chemical chaperone on genetic mutations in alpha-galactosidase A in Korean patients with Fabry disease.
Park JY; Kim GH; Kim SS; Ko JM; Lee JJ; Yoo HW
Exp Mol Med; 2009 Jan; 41(1):1-7. PubMed ID: 19287194
[TBL] [Abstract][Full Text] [Related]
31. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
32. A case of latent heterozygous Fabry disease in a female living kidney donor candidate.
Minami M; Mizuma E; Nakahara M; Oda Y; Yoshimine H; Tokunaga K; Mitsuke A; Yamada Y; Enokida H; Masutani K; Goto N; Ido A
CEN Case Rep; 2021 Feb; 10(1):30-34. PubMed ID: 32712909
[TBL] [Abstract][Full Text] [Related]
33. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
[TBL] [Abstract][Full Text] [Related]
34. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
Rosenthal D; Lien YH; Lager D; Lai LW; Shang S; Leung N; Fervenza FC
Am J Kidney Dis; 2004 Nov; 44(5):e85-9. PubMed ID: 15492942
[TBL] [Abstract][Full Text] [Related]
35. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yazaki M; Sakurai A; Endo F; Fukushima Y; Ikeda SI
Eur J Neurol; 2014; 21(1):49-56. PubMed ID: 23724928
[TBL] [Abstract][Full Text] [Related]
36. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns.
Lee BH; Heo SH; Kim GH; Park JY; Kim WS; Kang DH; Choe KH; Kim WH; Yang SH; Yoo HW
J Hum Genet; 2010 Aug; 55(8):512-7. PubMed ID: 20505683
[TBL] [Abstract][Full Text] [Related]
37. A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
Takahashi N; Yokoi S; Kasuno K; Kogami A; Tsukimura T; Togawa T; Saito S; Ohno K; Hara M; Kurosawa H; Hirayama Y; Kurose T; Yokoyama Y; Mikami D; Kimura H; Naiki H; Sakuraba H; Iwano M
Clin Nephrol; 2015 May; 83(5):301-8. PubMed ID: 25295576
[TBL] [Abstract][Full Text] [Related]
38. Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations.
Chien YH; Lee NC; Chiang SC; Desnick RJ; Hwu WL
Mol Med; 2012 Jul; 18(1):780-4. PubMed ID: 22437327
[TBL] [Abstract][Full Text] [Related]
39. Evolution of Fabry disease in male patients: the Greek experience.
Andrikos E; Iatrou C; Boletis JN; Diamandopoulos A; Katsinas C; Kalaitzidis K; Galinas A; Xaidara A; Pappas M; Siamopoulos KC
Clin Nephrol; 2010 Jan; 73(1):58-63. PubMed ID: 20040353
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.
Zhou C; Huang J; Cui G; Zeng H; Wang DW; Zhou Q
BMC Med Genet; 2018 Dec; 19(1):219. PubMed ID: 30587147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]